US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

186.09

+12.487.19%

Post-market: 186.970.8800+0.47%18:30 EDT

Volume:497.72K

Turnover:90.92M

Market Cap:544.22M

PE:- -

High:186.95

Open:172.61

Low:171.48

Close:173.61

52wk High:212.45

52wk Low:44.69

Shares:2.92M

Float Shares:2.92M

Volume Ratio:0.92

T/O Rate:17.02%

Dividend:1.23

Dividend Rate:0.66%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Regeneron (REGN) Receives a Buy from BMO Capital

Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK)

Analysts’ Opinions Are Mixed on These Real Estate Stocks: Camden Property (CPT), Omega Healthcare (OHI) and Weyerhaeuser (WY)

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

Press Release: Healthcare Realty Announces Proposed Exchangeable Senior Notes Offering

Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Icon (ICLR)

Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Hims & Hers Health (HIMS) and Insmed (INSM)

Press Release: National Healthcare Properties Announces $528 Million Sale of OMF Portfolio

Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Boston Scientific (BSX)

Arvinas price target raised to $24 from $21 at Citi

Analyst Maintains Buy on Sabio Despite Weak Results, Cuts Price Target to C$0.50 on Cyclical Ad-Tech Slowdown

Alkem Laboratories Gets 7 Observations from US FDA After Daman Plant Inspection

MT Newswires Live

Sigma Healthcare boosts Chemist Warehouse growth, enters UK and expands NZ logistics

Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Siemens Healthineers AG (OtherSEMHF)

SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations

A Look At Ionis Pharmaceuticals (IONS) Valuation After FDA Priority Review Wins And Upgraded Revenue Guidance

Simply Wall St.

Applied BioCode Unit Gets US FDA Nod for Respiratory Pathogen Panel

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":186.09,"timestamp":1777924800000,"preClose":173.61,"halted":0,"volume":497720,"hourTrading":{"tag":"盘后","latestPrice":186.97,"preClose":186.09,"latestTime":"18:30 EDT","volume":717,"amount":133974.18894000002,"timestamp":1777933840169,"change":0.88,"changeRate":0.004729,"amplitude":0.006341},"delay":0,"changeRate":0.07188526006566436,"floatShares":2924486,"shares":2924486,"eps":0,"marketStatus":"Post-Mkt","change":12.48,"latestTime":"05-04 18:37:45 EDT","open":172.61,"high":186.95,"low":171.48,"amount":90921648.036,"amplitude":0.089108,"askPrice":187.31,"askSize":1,"bidPrice":186.3,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1777939200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":173.61,"sharesOutstanding":3074486,"nav":173.83,"aum":508364160.45,"dividendRate":0.006624,"bidAskSpread":0.001954,"preHourTrading":{"tag":"盘前","latestPrice":171.4975,"preClose":173.61,"latestTime":"09:29 EDT","volume":1198,"amount":207829.12386000002,"timestamp":1777901381944,"change":-2.1125,"changeRate":-0.012168,"amplitude":0.024207},"postHourTrading":{"tag":"盘后","latestPrice":186.97,"preClose":186.09,"latestTime":"18:30 EDT","volume":717,"amount":133974.18894000002,"timestamp":1777933840169,"change":0.88,"changeRate":0.004729,"amplitude":0.006341},"volumeRatio":0.921955,"impliedVol":0.8271,"impliedVolPercentile":0.255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.921955,"shares":2924486,"dividePrice":1.2326,"high":186.95,"amplitude":0.089108,"preClose":173.61,"low":171.48,"week52Low":44.685,"pbRate":"--","week52High":212.45,"institutionHeld":0,"latestPrice":186.09,"committee":0.99005,"eps":0,"divideRate":0.006624,"volume":497720,"delay":0,"ttmEps":0,"open":172.61,"prevYearClose":159.39,"prevWeekClose":173.61,"prevMonthClose":177.56,"prevQuarterClose":166.09,"fiveDayClose":185.3,"twentyDayClose":170.45,"sixtyDayClose":149.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632584769","title":"After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2632584769","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632584769?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:00","pubTimestamp":1777896000,"startTime":"0","endTime":"0","summary":"FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker d","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286641/0/en/After-Successful-FDA-Meeting-Clene-Filing-Accelerated-Approval-NDA-for-ALS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU1923621640.USD","LU2089279066.USD","BK4585","BK4127","LU0882574139.USD","LU1244550577.SGD","LU1732799900.SGD","LU1791710400.SGD","LU2125910336.SGD","LU0267386448.USD","IE0009354923.USD","LU1244550221.USD","LU0320765646.SGD","LU1720051108.HKD","LU2271345857.HKD","LU2357305700.SGD","LABU","LU2125910179.SGD","BK4516","LU1732800096.USD","LU0314104364.USD","LU2023251221.USD","LU0225283273.USD","LU2111349929.HKD","BK4539","BK4534","LU1791710582.SGD","LU0795875086.SGD","LU0106831901.USD","LU2133065610.SGD","BK4104","LU2347655156.SGD","LU2229751404.USD","LU0912757837.SGD","LU1363072403.SGD","IE00BKVL7J92.USD","LU1162221912.USD","BK4588","LU0098860793.USD","CNM","IE00BZ1G4Q59.USD","LU1989772840.SGD","LU2028103732.USD","LU0106261372.USD","LU1548497426.USD","LU1989772923.USD","LU2089283258.USD","LU0158827781.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632581849","title":"Regeneron (REGN) Receives a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2632581849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632581849?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:56","pubTimestamp":1777895804,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Evan Seigerman maintained a Buy rating on Regeneron today and set a price target of $900.00. Seigerman covers the Healthcare se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","XLV","LU0823434583.USD","BK4585","LU2362540622.SGD","LU2468319806.SGD","XBI","BK4139","LU0882574055.USD","LU1974910355.USD","LU2237438978.USD","LU0053666078.USD","LU2362541513.USD","LU0289739699.SGD","LU2106854487.HKD","BK4588","REGN","LU0889565916.HKD","LU0109394709.USD","LABU","LU0320765992.SGD","BK4581","LU1917777945.USD","LU2023250504.SGD","LU0114720955.EUR","LU0058720904.USD","BMO","BK4207","LU0823434740.USD","LU0823416689.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632307969","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632307969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632307969?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:41","pubTimestamp":1777894897,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Climb Bio (CLYM), ICU Medical (ICUI) and Stryker (SYK). Climb Bio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-climb-bio-clym-icu-medical-icui-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-climb-bio-clym-icu-medical-icui-and-stryker-syk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2506952170.USD","LU2506951958.HKD","BK4566","LU0205194284.USD","LU0690374961.EUR","LU0240878834.USD","SG9999015952.SGD","GB00B4LPDJ14.GBP","LU2089984988.USD","LU0528227936.USD","LU2506952097.USD","LU0950375773.USD","LU2362541273.HKD","LU0690374615.EUR","LU0029874061.USD","LU2362541513.USD","LABU","LU0106261612.USD","LU0432979614.USD","LU1791710400.SGD","LU2468319806.SGD","LU2362540622.SGD","BK4082","LU1791710582.SGD","HCSG","LU2404859667.USD","BK4198","LU1983299246.USD","LU0012050646.USD","SG9999015978.USD","BK4139","BK4504","LU0114720955.EUR","BK4137","SYK","LU0882574055.USD","LU0289739699.SGD","GB00B4QBRK32.GBP","ICU","LU0240877869.USD","BK4585","LU2324357040.USD","LU2506951875.HKD","SG9999015945.SGD","CLYM","XLV","SG9999015986.USD","LU0823417653.USD","ICUI","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632993074","title":"Analysts’ Opinions Are Mixed on These Real Estate Stocks: Camden Property (CPT), Omega Healthcare (OHI) and Weyerhaeuser (WY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632993074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632993074?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:40","pubTimestamp":1777894846,"startTime":"0","endTime":"0","summary":"Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Camden Property (CPT), Omega Healthcare (OHI) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-real-estate-stocks-camden-property-cpt-omega-healthcare-ohi-and-weyerhaeuser-wy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-real-estate-stocks-camden-property-cpt-omega-healthcare-ohi-and-weyerhaeuser-wy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4225","LABU","XBI","BK4588","BK4084","XLV","BK4221","BK4215","CPT","BK4203","BK4581","BK4585","WY","OHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632958808","title":"MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2632958808","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632958808?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894200,"startTime":"0","endTime":"0","summary":" MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard), with the potential to receive an additional near-term sales-based milestone of up to $20 millionROCKVILLE, MD, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/04/3286588/0/en/MacroGenics-and-Sagard-Healthcare-Partners-Enter-into-Expanded-ZYNYZ-Royalty-Purchase-Agreement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","BK4588","BK4581","XLV","XBI","LU0128526141.USD","LU0029874061.USD","LABU","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930340","title":"Press Release: Healthcare Realty Announces Proposed Exchangeable Senior Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930340?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:23","pubTimestamp":1777893780,"startTime":"0","endTime":"0","summary":"NASHVILLE, Tenn., May 04, 2026  -- Healthcare Realty Trust Incorporated   today announced that its operating partnership, Healthcare Realty Holdings, L.P. , intends to offer, subject to market and other conditions, $500,000,000 aggregate principal amount of exchangeable senior notes due 2032  in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended . Healthcare Realty will fully and unconditionally guarantee the notes on a senior, unsecured basis. Healthcare Realty L.P. also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $75,000,000 aggregate principal amount of notes.The notes will be entitled to the benefits of a registration rights agreement pursuant to which Healthcare Realty will agree to register, under the Securities Act, the resale o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4225","BK4588","LU0029874061.USD","BK4581","BK4137","HCSG","BK4203","XLV","LU0128526141.USD","XBI","HR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632619937","title":"Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Icon (ICLR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632619937","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632619937?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:01","pubTimestamp":1777892474,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eli Lilly & Co (LLY) and Icon (ICLR) with bullish se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-eli-lilly-co-lly-icon-iclr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-eli-lilly-co-lly-icon-iclr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0310800379.SGD","LU0787776722.HKD","LU2271345857.HKD","LU1064131342.USD","LU2112291526.USD","LU2756315664.SGD","LU0426412945.USD","LU2089984988.USD","LU2237443465.HKD","LU2213496289.HKD","LU2237443895.HKD","LU0466842654.USD","LU0882574055.USD","LU0882574139.USD","LU0417517546.SGD","LU0786609619.USD","LU1720051017.SGD","LU2211815571.USD","IE0005OL40V9.USD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","LU2023250330.USD","LU0097036916.USD","IE00BKPKM429.USD","SG9999014906.USD","LU2602419157.SGD","IE00BKDWB100.SGD","BK4581","LU1145028129.USD","LU2552382132.HKD","LU2237443549.SGD","LU1712237335.SGD","LU0320765059.SGD","LU0187121727.USD","LU2362540622.SGD","LU2471134796.USD","LU2471134879.HKD","LU0114720955.EUR","LU1548497426.USD","LU2462157665.USD","LU1917777945.USD","LU2023251221.USD","SG9999018857.SGD","LU2237443622.USD","LU0820561818.USD","LU2087625088.SGD","BK4112","LU1061106388.HKD","LU1232071149.USD","LU0683600562.USD","LU1629891620.HKD","BK4007","LU1691799644.USD","LU1804176565.USD","LU0511384066.AUD","LU1868836757.USD","ELIS","IE00B4JS1V06.HKD","LU2111349929.HKD","LU2491050071.SGD","IE00BK4W5L77.USD","LU2552382215.SGD","IE0004445015.USD","BK4533","LU0354030511.USD","SG9999015945.SGD","LU2168564149.EUR","LU0109394709.USD","IE00BK4W5M84.HKD","LU1043141396.HKD","LU0471298777.SGD","LU0640476718.USD","SGXZ31699556.SGD","LU1043141123.HKD","LU0708995401.HKD","LU1267930730.SGD","LU2237443978.SGD","LU0058720904.USD","LU2552382058.USD","LU0079474960.USD","LU0823434583.USD","LU2108987350.USD","SG9999013999.USD","LU0320765992.SGD","LU2106854487.HKD","BK4599","LU0109391861.USD","SGXZ99366536.SGD","LU0289739699.SGD","ELIL","LU0061475181.USD","LU0289961442.SGD","LU1623119135.USD","LU2168564495.EUR","LU0096364046.USD","SG9999014880.SGD","LU0006306889.USD","ICLR","LU2361045086.USD","LU0994945656.USD","SG9999015978.USD","LU1868836914.USD","BLSX","SG9999018865.SGD","BK4532","LU2456880835.USD","LU1989771016.USD","LU0203201768.USD","LU2756315318.SGD","IE0004445239.USD","LU0069063385.USD","IE00BJJMRX11.SGD","LU2417539215.USD","IE00BN29S564.USD","LU0057025933.USD","LU1791710582.SGD","BK4534","LU0029874061.USD","LU0456855351.SGD","LU2746668461.USD","LU2264538146.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","LU2896262040.SGD","LU0203202063.USD","SGXZ51526630.SGD","LU2750360641.GBP","LU2468319806.SGD","LU0029864427.USD","LU0256863902.USD","LU0823416689.USD","LU1983260115.SGD","IE00BJJMRY28.SGD","IE00BWXC8680.SGD","LU0471298694.HKD","IE00BJJMRZ35.SGD","LU0823434740.USD","SG9999017495.SGD","LU1267930813.SGD","LU0234572021.USD","LLY","LU1988902786.USD","IE00BFSS8Q28.SGD","XBI","LU2089283258.USD","LU0385154629.USD","IE0009355771.USD","LU0210536198.USD","LU2491050154.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0323591593.USD","LU2361044949.HKD","LU0353189763.USD","LU0792757196.USD","LU0175139822.USD","LU0106261372.USD","IE00B775H168.HKD","LU2168564065.EUR","SG9999001176.SGD","LU0426417589.USD","LU0158827948.USD","LU1267930573.SGD","LU0943347566.SGD","SGXZ81514606.USD","LU0689472784.USD","SG9999014898.SGD","BK4516","LU0128525929.USD","LU1069344957.HKD","LU2089284900.SGD","LU0133085943.USD","SG9999014914.USD","BK4588","IE00B1XK9C88.USD","LU0238689110.USD","LU1814569148.SGD","LU2746668974.SGD","LU2244417387.USD","LU0672654240.SGD","LU1093756325.SGD","LU2168564222.USD","LU0964807845.USD","LU0528227936.USD","LU0889565916.HKD","LU0122379950.USD","IE00B2B36J28.USD","LU0354030438.USD","LU1093756168.USD","LU1023059063.AUD","LU2063271972.USD","LU1291159041.SGD","LU0889566641.SGD","LU2023250504.SGD","LU1551013425.SGD","LU2461242641.AUD","LU0820561909.HKD","LLYZ","LLII","LU2471134523.USD","LU2362541513.USD","SG9999015986.USD","SGXZ57979304.SGD","LU0094547139.USD","IE00BFSS7M15.SGD","LU1035775433.USD","LU1868836591.USD","LU2265009873.SGD","GB00BDT5M118.USD","LU0289739343.SGD","LU1280957306.USD","BK4585","LU1791710400.SGD","LU0198837287.USD","LU1720051108.HKD","LU1868837300.USD","LU0708994859.HKD","LU1057294990.SGD","LU0128526141.USD","LU2491049909.HKD","LU0820562030.AUD","LU1127390331.HKD","BK4121","IE0002141913.USD","LU0256863811.USD","SG9999001176.USD","SG9999015952.SGD","LU0266013472.USD","IE00B7KXQ091.USD","LU2357305700.SGD","LU2237438978.USD","BK4137","LU2324357040.USD","LU0225283273.USD","LU0316494557.USD","LU1121112475.USD","IE00BFTCPJ56.SGD","LU2360106947.USD","LU1323610961.USD","LU2471134952.CNY","LU0432979614.USD","LU2236285917.USD","LABU","LU0353189680.USD","LU2237443382.USD","LU2362541273.HKD","LU1983299246.USD","LU2028103732.USD","IE00BJT1NW94.SGD","LU0158827781.USD","BLSG","LU0472753341.HKD","LLYX","LU1551013342.USD","LU0728928796.USD","LU1868837136.USD","LU2750360997.AUD","LU1366192091.USD","LU0289960550.SGD","LU2361044865.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932452","title":"Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632932452?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:36","pubTimestamp":1777890962,"startTime":"0","endTime":"0","summary":"Rezolute, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Douglas Tsao from H.C. Wainwright maintained a Buy r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reiterated-as-cgm-data-offset-phase-3-miss-5-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reiterated-as-cgm-data-offset-phase-3-miss-5-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632417932","title":"Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632417932","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632417932?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:30","pubTimestamp":1777890617,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assembly Biosciences (ASMB), Artiva Biotherapeutics,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-artiva-biotherapeutics-inc-artv-and-emergent-biosolutions-ebs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-artiva-biotherapeutics-inc-artv-and-emergent-biosolutions-ebs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4585","LU0029874061.USD","XBI","XLV","ARTV","BK4139","LABU","BK4583","HCSG","BK4581","BK4588","EBS","LU0128526141.USD","ASMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632869932","title":"Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Hims & Hers Health (HIMS) and Insmed (INSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632869932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632869932?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:10","pubTimestamp":1777889436,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on HeartFlow, Inc. (HTFL), Hims & Hers Health (HIMS) and Insmed (INS...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heartflow-inc-htfl-hims-hers-health-hims-and-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heartflow-inc-htfl-hims-hers-health-hims-and-insmed-insm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","HIMZ","HIYY","BK4196","BK4588","BK4137","LU0109394709.USD","LU0053671581.USD","LU0029874061.USD","INSM","BK4585","XBI","LABU","BK4167","HIMS","LU0128526141.USD","HTFL","HIMY","HMYY","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632934320","title":"Press Release: National Healthcare Properties Announces $528 Million Sale of OMF Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2632934320","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632934320?lang=en_us&edition=fundamental","pubTime":"2026-05-04 18:00","pubTimestamp":1777888800,"startTime":"0","endTime":"0","summary":"NEW YORK, May 04, 2026  -- National Healthcare Properties, Inc.   announced today that it has entered into a definitive purchase and sale agreement to sell a portfolio of 86 outpatient medical facilities  for approximately $528 million.Inclusive of this transaction and approximately $90 million of pending SHOP acquisitions under definitive purchase and sale agreements, fourth quarter 2025 cash NOI from the SHOP segment would have represented approximately 60% of total portfolio cash NOI. In addition to increasing NHP's relative exposure to the SHOP segment, the disposition is expected to, subject to closing, result in the defeasance or transfer of approximately $278 million of debt with a weighted average coupon of approximately 5.9% and generate approximately $250 million of potential cash proceeds . The Company expects to use anticipated net proceeds, together with approximately $500 million in net cash proceeds from its recent initial public offering, for deleveraging, execution of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4166","NHP","XBI","BK4225","BK4561","BK4588","LABU","XLV","BK4581","OMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632393191","title":"Analysts Offer Insights on Healthcare Companies: Celcuity (CELC) and Boston Scientific (BSX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632393191","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632393191?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:20","pubTimestamp":1777886459,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Celcuity (CELC) and Boston Scientific (BSX) with bul...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celcuity-celc-and-boston-scientific-bsx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-celcuity-celc-and-boston-scientific-bsx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2491050071.SGD","CELC","BK4588","LU2112291526.USD","LU0823417737.USD","LU0128526141.USD","IE00BFTCPJ56.SGD","LU0353189680.USD","LU1061106388.HKD","BK4137","LU0353189763.USD","LU1291159041.SGD","LU2087625088.SGD","LU1989764664.SGD","XLV","XBI","LU1791710400.SGD","LU2324357040.USD","LU0138981039.USD","LU2506951875.HKD","LU0432979614.USD","IE00BJJMRZ35.SGD","LU2491049909.HKD","SG9999013999.USD","LU2491050154.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1153585028.USD","LU0122379950.USD","LU0251132253.USD","LU1989772840.SGD","LU0345769128.USD","LU1989771016.USD","LU0823416689.USD","SG9999001176.USD","LU1548497426.USD","LU2242649171.HKD","LU0225283273.USD","BSX","LU0114720955.EUR","LABU","HCSG","LU2362541513.USD","LU0267386448.USD","LU0345769631.USD","LU0029874061.USD","BK4082","BK4581","IE00B2B36J28.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632693190","title":"Arvinas price target raised to $24 from $21 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2632693190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632693190?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:10","pubTimestamp":1777885810,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Arvinas (ARVN) to $24 from $21 and keeps a Buy rating on the shares after the company received FDA approval ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arvinas-price-target-raised-to-24-from-21-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arvinas-price-target-raised-to-24-from-21-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","ARVN","BK4007","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632970931","title":"Analyst Maintains Buy on Sabio Despite Weak Results, Cuts Price Target to C$0.50 on Cyclical Ad-Tech Slowdown","url":"https://stock-news.laohu8.com/highlight/detail?id=2632970931","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632970931?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:05","pubTimestamp":1777885526,"startTime":"0","endTime":"0","summary":"Sabio Holdings, the Healthcare sector company, was revisited by a Wall Street analyst on May 1. Analyst Nicholas Cortellucci from Atrium Research m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sabio-despite-weak-results-cuts-price-target-to-c0-50-on-cyclical-ad-tech-slowdown-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-sabio-despite-weak-results-cuts-price-target-to-c0-50-on-cyclical-ad-tech-slowdown-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","LABU","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632939254","title":"Alkem Laboratories Gets 7 Observations from US FDA After Daman Plant Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2632939254","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632939254?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:52","pubTimestamp":1777884747,"startTime":"0","endTime":"0","summary":"Alkem Laboratories  said it has received Form 483 with seven observations from the U.S. Food and Drug Administration after inspection of its manufacturing facility in Daman, India, according to a Saturday filing on Indian bourses.Shares of the company fell nearly 1% in Monday's trade.The inspection was conducted from April 20 to May 1, the filing said.The company said it will respond to the observations within the specified timeframe.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632936325","title":"Sigma Healthcare boosts Chemist Warehouse growth, enters UK and expands NZ logistics","url":"https://stock-news.laohu8.com/highlight/detail?id=2632936325","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632936325?lang=en_us&edition=fundamental","pubTime":"2026-05-04 15:27","pubTimestamp":1777879635,"startTime":"0","endTime":"0","summary":"Sigma Healthcare Ltd ( ($AU:SIG) ) has provided an announcement. Sigma Healthcare reported robust sales growth across Chemist Warehouse branded sto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-boosts-chemist-warehouse-growth-enters-uk-and-expands-nz-logistics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-boosts-chemist-warehouse-growth-enters-uk-and-expands-nz-logistics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","HCSG","LU0128526141.USD","BK4137","LABU","XBI","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632352469","title":"Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Siemens Healthineers AG (OtherSEMHF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632352469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632352469?lang=en_us&edition=fundamental","pubTime":"2026-05-04 15:20","pubTimestamp":1777879205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Anteris Technologies Global Corp. (AVR) and Siemens ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-anteris-technologies-global-corp-avr-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-anteris-technologies-global-corp-avr-and-siemens-healthineers-ag-othersemhf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","AG","BK4588","BK4585","XLV","XBI","BK4210","LU0128526141.USD","LU0029874061.USD","BK4082","LABU","AVR","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632335539","title":"SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations","url":"https://stock-news.laohu8.com/highlight/detail?id=2632335539","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632335539?lang=en_us&edition=fundamental","pubTime":"2026-05-04 14:00","pubTimestamp":1777874400,"startTime":"0","endTime":"0","summary":"Median Tmax of 10 minutes for SPONTAN  versus 60 minutes for oral vardenafil , consistent with Phase I study.Interim data provide the key pharmacokinetic dataset requested by the FDA, including rapid absorption, repeat-dose profile, with no drug accumulation observed, and consistent pharmacokinetics across adult and geriatric populations.Pharmacokinetic profile in subjects ≥65 years comparable to adults in the dataset, addressing a key FDA Pre-IND requirement.Consistent safety profile observed, with no serious adverse events, no Grade 3 or 4 treatment-emergent adverse events, and no treatment-related discontinuations.Interim data are expected to inform the Company's planned FDA 505 regulatory pathway.SPONTAN Phase II study design. Randomised, three-way crossover  followed by multiple-dose evaluation .The interim results indicate that the Study has characterised the key pharmacokinetic parameters requested by the FDA, including rapid absorption, repeat-dose behaviour, and consistency ac","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2971713/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2971713/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/spontan-phase-ii-interim-data-demonstrates-rapid-onset-and-pharmacokinetic-profile-addressing-fda-pre-ind-requirements-across-adult-and-65-populations-302761066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK4218","LTP.AU","BK4181","LABU","BK4585","IND","PK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632933138","title":"A Look At Ionis Pharmaceuticals (IONS) Valuation After FDA Priority Review Wins And Upgraded Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2632933138","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632933138?lang=en_us&edition=fundamental","pubTime":"2026-05-04 13:13","pubTimestamp":1777871595,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals (IONS) has been in focus after a busy stretch that included US FDA Priority Review and Breakthrough Therapy designations for partner drug bepirovirsen, additional positive zilganersen data in Alexander disease, and a first quarter earnings update.\nSee our latest analysis for Ionis Pharmaceuticals.\nThe recent FDA designations for bepirovirsen, encouraging zilganersen data and raised 2026 revenue guidance help explain why Ionis Pharmaceuticals has a 1-year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ions/ionis-pharmaceuticals/news/a-look-at-ionis-pharmaceuticals-ions-valuation-after-fda-pri","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ions/ionis-pharmaceuticals/news/a-look-at-ionis-pharmaceuticals-ions-valuation-after-fda-pri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IONS","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632980639","title":"Applied BioCode Unit Gets US FDA Nod for Respiratory Pathogen Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2632980639","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632980639?lang=en_us&edition=fundamental","pubTime":"2026-05-04 12:27","pubTimestamp":1777868852,"startTime":"0","endTime":"0","summary":"Applied BioCode's  US unit has secured a 510 clearance from the U.S. FDA for its respiratory pathogen panel, according to a Monday Taiwan Exchange filing.The approval allows the panel to be used with the BioCode MDx 3000 system alongside Thermo Fisher Scientific's KingFisher extraction platform, adding to existing compatibility with systems from bioMérieux and Roche.The company said the clearance enables sales of the combined solution in the US, offers labs greater flexibility in extraction systems, and is expected to support its business and financial performance.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":24,"pageCount":2,"totalSize":475,"code":"91000000","status":"200"}]}}